A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Journal of Advanced Research · 2023-12 · 54 · 271-292
DOI: 10.1016/j.jare.2023.02.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Advanced Research, 2023-12. Verfasst von Hitesh Kumar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
BACKGROUND: Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive phenotype of breast cancer with associated chemoresistance. The development of chemo- or radioresistance could be attributed to diverse tumor microenvironments, overexpression of membrane proteins (transporters), epigenetic changes, and alteration of the cell signaling pathways/genes associated with the development of cancer stem cells (CSCs). AIM OF REVIEW: Due to the diverse and heterogeneous nature of TNBC, therapeutic response to the existing modalities offers limited scope and thus results in reccurance after therapy. To establish landmark therapeutic efficacy, a number of novel therapeutic modalities have been proposed. In addition, reversal of the resistance that developed during treatment may be altered by employing appropriate therapeutic modalities. This review aims to discuss the plethora of investigations carried out, which will help readers understand and make an appropriate choice of therapy directed toward complete elimination of TNBC. KEY SCIENTIFIC CONCEPTS OF REVIEW: This manuscript addresses the major contributory factors from the tumor microenvironment that are responsible for the development of chemoresistance and poor prognosis. The associated cellular events and molecular mechanism-based therapeutic interventions have been explained in detail. Inhibition of ABC transporters, cell signaling pathways associated with CSCs, and epigenetic modification offers promising results in this regard. TNBC progression, invasion, metastasis and recurrence can also be inhibited by blocking multiple cell signaling pathways, targeting specific receptors/epigenetic targets, disrupting bioenergetics and generating reactive oxygen species (ROS).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, India.
- Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, India.
- Department of Biochemistry, Centre of Excellence in Molecular Biology & Regenerative Medicine, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru 570015, India.
- Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, India.
- Roseman University of Health Sciences, College of Pharmacy, South Jordan, UT, USA.
- Roseman University of Health Sciences, College of Pharmacy, Henderson, NV, USA.
Förderung
- Science and Engineering Research Board
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Kumar, H., Gupta, N. V., Jain, R., Madhunapantula, S. V., Babu, C. S., Kesharwani, S. S., Dey, S., & Jain, V. (2023). A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer. Journal of Advanced Research, 54, 271-292. https://doi.org/10.1016/j.jare.2023.02.005
Vancouver
Kumar H, Gupta NV, Jain R, Madhunapantula SV, Babu CS, Kesharwani SS, et al. A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer. Journal of Advanced Research. 2023;54:271-292. doi:10.1016/j.jare.2023.02.005
BibTeX
@article{Kumar2023,
author = {Kumar, Hitesh and Gupta, N Vishal and Jain, Rupshee and Madhunapantula, SubbaRao V and Babu, C Saravana and Kesharwani, Siddharth S and Dey, Surajit and Jain, Vikas},
title = {A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer},
journal = {Journal of Advanced Research},
year = {2023},
volume = {54},
pages = {271--292},
doi = {10.1016/j.jare.2023.02.005}
}
EUVIMED